MedPath

PHARMORIX RECOGZYN CAPSULE

Registration Number: MAL18106013NC

Approved
Approval ID

8eaa6203f14cd8c1

Registration Number

MAL18106013NC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types7 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (7)

100 CapsulesAvailable
Package Size: 100 Capsules
Status: NPRA Approved
30 CapsulesAvailable
Package Size: 30 Capsules
Status: NPRA Approved
60 CapsulesAvailable
Package Size: 60 Capsules
Status: NPRA Approved
90 CapsulesAvailable
Package Size: 90 Capsules
Status: NPRA Approved
120 CapsulesAvailable
Package Size: 120 Capsules
Status: NPRA Approved
150 CapsulesAvailable
Package Size: 150 Capsules
Status: NPRA Approved
180 CapsulesAvailable
Package Size: 180 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (3)

CITICOLINEActive
Monograph: 脑二磷胆碱
GINKGO BILOBA LEAF EXTRACTActive
Monograph: ginkgo biloba leaf extract
L-CARNITINE FUMARATEActive
Monograph: l-carnitine fumarate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PHARMORIX RECOGZYN CAPSULE - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform